In contrast, circulating tumor cells (CTCs), the cancer cells that detach from the tumor and circulate in the peripheral blood as the cellular origin of metastasis, may offer a promising alternative for real-time HER2 detection with the advantages of minimal invasiveness and convenient accessibility [14–17]. This evidence concerns the gene ERBB2 and neoplasm.